Dupont Capital Management Corp Corcept Therapeutics Inc Transaction History

Dupont Capital Management Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$17.33 - $25.3 $229,761 - $335,427	-13,258 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$16.53 - $25.21 $19,389 - $29,571	-1,173 Reduced 8.13%	13,258 $299,000
Q4 2021 Jan 31, 2022	SELL	$17.1 - $23.34 $98,393 - $134,298	-5,754 Reduced 28.51%	14,431 $286,000
Q3 2021 Nov 03, 2021	SELL	$19.68 - $22.53 $258,024 - $295,390	-13,111 Reduced 39.38%	20,185 $397,000
Q1 2021 Apr 29, 2021	SELL	$23.49 - $30.56 $160,413 - $208,694	-6,829 Reduced 17.02%	33,296 $792,000
Q4 2020 Jan 28, 2021	SELL	$16.78 - $27.3 $50,256 - $81,763	-2,995 Reduced 6.95%	40,125 $1.05 Million
Q3 2020 Oct 29, 2020	BUY	$12.46 - $19.98 $111,554 - $178,880	8,953 Added 26.2%	43,120 $751,000
Q2 2020 Jul 24, 2020	SELL	$11.0 - $18.26 $33,561 - $55,711	-3,051 Reduced 8.2%	34,167 $575,000
Q1 2020 Apr 29, 2020	SELL	$10.11 - $14.04 $555,129 - $770,922	-54,909 Reduced 59.6%	37,218 $443,000
Q4 2019 Jan 27, 2020	BUY	$12.06 - $16.96 $99,760 - $140,293	8,272 Added 9.86%	92,127 $1.12 Million
Q3 2019 Oct 28, 2019	SELL	$10.41 - $14.66 $93,585 - $131,793	-8,990 Reduced 9.68%	83,855 $1.19 Million
Q1 2018 May 02, 2018	SELL	$14.59 - $25.5 $360,285 - $629,697	-24,694 Reduced 21.01%	92,845 $1.53 Million
Q3 2017 Oct 31, 2017	BUY	$12.3 - $19.3 $1.45 Million - $2.27 Million	117,539	117,539 $2.27 Million

359

86.3M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.33B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.